Description
neuroCORE GlioSeq is a diagnostic test offered by CORE Diagnostics, utilizing next-generation sequencing (NGS) to analyze genetic alterations in brain tumors. It aims to provide comprehensive molecular profiling of CNS tumors, aiding in accurate diagnosis, prognosis, and personalized treatment strategies. The test can be performed on formalin-fixed, paraffin-embedded (FFPE) samples, enabling its use on archived tissue.
Reviews
There are no reviews yet.